Verve Therapeutics Ratios and Metrics

Market cap in millions ISK. Fiscal year is January - December.

Millions ISK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jul '25 Jul 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	242,071	235,931	219,846	219,208	289,438	163,305	Upgrade
Market Cap Growth	27.74%	7.32%	0.29%	-24.26%	77.24%	6.40%	Upgrade
Last Close Price	175.00	155.18	133.15	123.47	144.53	71.02	Upgrade
PE Ratio	7.49	9.04	8.54	8.45	10.12	13.09	Upgrade
PS Ratio	3.20	3.58	3.58	3.96	4.76	3.56	Upgrade
PB Ratio	1.19	1.14	1.10	1.17	1.49	0.83	Upgrade
P/FCF Ratio	-	-	-	3.84	-	-	Upgrade
P/OCF Ratio	-	-	-	3.82	-	-	Upgrade
Debt / Equity Ratio	2.61	2.38	2.39	2.52	2.07	1.79	Upgrade
Debt / FCF Ratio	-	-	-	8.30	-	-	Upgrade
Return on Equity (ROE)	17.29%	12.87%	13.29%	10.15%	13.87%	8.64%	Upgrade
Return on Assets (ROA)	2.09%	1.66%	1.72%	1.40%	2.19%	1.49%	Upgrade
Earnings Yield	13.36%	11.07%	11.71%	11.84%	9.88%	7.64%	Upgrade
FCF Yield	-34.07%	-19.33%	-19.20%	26.02%	-9.24%	-76.76%	Upgrade
Dividend Yield	6.57%	7.41%	6.76%	6.88%	10.38%	2.45%	Upgrade
Payout Ratio	49.84%	50.01%	47.98%	86.68%	9.99%	-	Upgrade
Buyback Yield / Dilution	-	5.38%	3.24%	6.75%	1.92%	4.75%	Upgrade
Total Shareholder Return	6.46%	12.79%	9.99%	13.63%	12.29%	7.20%	Upgrade

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.